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The non-tumour promoting irritant, resiniferatoxin, was capable of activating the NADPH-oxidase respiratory burst of starch-elicited, but not 
resident mouse peritoneal macrophages in vitro. Unlike TPA, the response was synergised by incubation with zymosan. The Rx-stimulated 
NADPH-oxidase activity in a cell-free assay was selectively enhanced in the presence of exogenous Rx-kinase rather than PKC and in the absence 
of Ca*+. Since resiniferatoxin is a poor activator of PKC, it is probable that the Ca2+-independent Rx-kinase plays a role in activation of the 
macrophage respiratory burst following stimulation by zymosan. 
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1. INTRODUCTION 
Macrophages can undergo a burst of cyanide- 
insensitive respiratory activity in response to both solu- 
ble and particulate stimuli, resulting in the production 
of toxic oxygen species (notably superoxide anion, 0;). 
These form part of the host immune defence system [11. 
Phorbol esters, such as TPA, are well known activators 
of this response [2,3], which has been linked in a cell- 
free system to phosphorylation of a component of the 
NADPH-oxidase/cytochrome b complex by PKC, the 
phorbol ester receptor [4]. Irritancy is a common toxic 
feature of trans-AB ring diterpene esters [5], but does 
not correlate directly with in vitro activation of PKC 
[6]. Recently, we demonstrated that the diterpene or- 
thoester resiniferatoxin (Rx) was more potent than 
TPA in activating a Ca2+ -inhibited kinase activity (Rx- 
kinase) from human mononuclear leukocytes. The en- 
zyme was distinct from the presently recognised 
isozymes of PKC [7]. Rx is a weak activator of mam- 
malian brain PKC [6], yet is a hundred times more irri- 
tant than TPA in the mouse ear erythema test [8]. In 
this communication a biological role for this kinase has 
been studied by comparing features of the respiratory 
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burst activation in mouse peritoneal macrophages by 
TPA and Rx. 
2. MATERIALS AND METHODS 
2.1. Macrophage culture 
Peritoneal cells were obtained by aseptic lavage of the peritoneal 
cavity of male CD1 mice (-20 g body weight) with 10 ml RPM1 1640 
medium containing 50 pg/ml gentamycin (Flow Labs., Irvine). The 
mice were either untreated or had been given 2 ml of 2% starch solu- 
tion i.p. three days prior to harvesting cells (see section 3). After 
washing by centrifugation (400 x g, x 2) the cells were resuspended 
in RPM1 1640 medium supplemented with 10% foetal calf serum, 2% 
glutamine and SOpg/ml gentamycin at a density of lO’/ml viable 
cells (optimal for OF production) and aliquots dispensed into 
microtitre wells. After 24 h incubation at 37°C (in humidified 5% 
CO2/95% air) non-adherent cells were aspirated off. The resulting 
monolayer was >95% macrophages as judged by morphology of cells 
in Giemsa stained smears. 
For cell-free assays of NADPH-oxidase activity, lo*-lo9 starch 
elicited mouse peritoneal macrophages were suspended in cold 
40 mM Tris-Cl, pH 7.5, containing 10 mM EDTA, 1 mM MgCls, 
2 mM NaNs, 2 mM PMSF, 2 mM leupeptin and 10% w/v sucrose. 
Cells were lysed by sonication (3 x 10 s pulses of 150 W) on ice. 
Nuclei and unbroken cells were removed by centrifugation (1100 x g 
x 10 min) and the post-nuclear supernatant layered onto a discon- 
tinuous sucrose gradient (10%/40%, w/v) and centrifuged at 100000 
x g for 60 min. The 10% sucrose layer was recentrifuged at 100000 
x g for 2 h and the supernatant stored at -70°C (cytosolic factor). 
The membrane-bound oxidase activity was recovered from 40% 
sucrose layer and also stored at -70°C. 
2.2. Assay of superoxide OZ- production 
Superoxide inhibitable 0: production was measured at 37°C by 
determining reduction of ferricytochrome c spectroscopically 
(550 nm) essentially by the method of Johnston [9]. Diterpene esters 
were added in 10 ~1 of 50% ethanol, and opsonised zymosan in 40 pl 
of buffer where appropriate. Cells were incubated in the assay mix 
for 2 h prior to spectroscopic measurement. (Or production 
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plateaued between 1.75 and 2.5 h for all doses and compounds 
tested.) The reference cuvettes contained an additional 150 U 
superoxide dismutase (Sigma, Poole). For assay of solubilised 
NADPH-oxidase activity a modification of the above assay was used 
(see Fig. 2) and rate of 02 production monitored continuously to ob- 
tain the initial linear rate/minute. Activity was proportional to 
amount of extract added (2.32 nmol/min/lOO~l extract for 
unstimulated enzymes). For exogenous kinase addition, the assay mix 
also contained 1OOpM ATP, 10 mM MgCl2, 10 mM EGTA (or 
520pM CaCl2) and 5 pg phosphatidyl serine (Lipid Products, Sur- 
rey). The protein content of representative cultures was determined 
using a Sigma Protein Assay Kit. 
2.3. Hydroxylapatite chromatography 
Starch-elicited peritoneal macrophages were enriched by incuba- 
tion on a Sephadex G25 column (30 min at 3O”C), and following elu- 
tion of non-adherent cells, recovery by washing with ice-cold 5 mM 
EGTA in PBS. Approximately lo* cells per ml were suspended in 
buffer A (20 mM Tris, 0.25 M sucrose, lOO/rg/ml leupeptin, 10 mM 
EGTA, 2 mM EDTA, 1 mM DTT, pH 7.5) and lysed by sonication 
on ice. After centrifugation at 15000 x g, the supernatant was ap- 
plied to a hydroxylapatite column (Biomed HTP Biogel) on an FPLC 
machine, After washing with buffer B (20 mM potassium phosphate, 
1 mM EGTA, 10% glycerol, 1 mM DTT, pH 7.5) proteins were 
eluted in a linear phosphate gradient (20-500 mM). Fractions were 
stored at -80°C in 16”10 glycerol/0.02% Triton for up to 6 days 
before assay. 
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2.4. Assay of kinase activity 
Kinase activity was determined by measuring the transfer of ‘*P 
from [y-‘*P]ATP (Amersham International) to histone 111s (Sigma, 
Poole), using essentially the micellar assay of Hannum et al. [lo]. 
Triton micelles contained 20% PS (w/w) (Lipid Products, Nutfield, 
Surrey) and diterpene sters in a ratio of 0.003% where appropriate. 
The assay was terminated after 6 min (within the linear range) with 
10% TCA, and precipitated proteins separated by filtration (What- 
man GF/C filters). 
Fig. 1. Stimulation of maximal superoxide production by diterpene 
esters and zymosan in starch-elicited mouse peritoneal macrophage 
monolayer cultures. Peritoneal cells were initially seeded at a density 
of 10’ cells/ml - optimal for 0; production in this system. Results 
show nmol 0; released per mg protein determined spectroscopically 
as maximal SOD-inhibitable cytochrome c reduction. Or release 
plateaued between 1.75 and 2.5 h for all compounds and at all doses 
tested. The assay mix contained 4 mM glucose, 10 mg/ml BSA, 
80 ,uM cytochrome c, 150 units SOD (controls only) in 0.1 M 
phosphate-buffered saline (pH 7.5). Data are the mean of 3 
experiments. (0) Rx alone; (0) Rx and zymosan; (m) TPA alone; (0) 
3. RESULTS AND DISCUSSION TPA and zymosan. 
The oxidative burst of peritoneal macrophages was 
strongly stimulated by TPA treatment; maximal rate of 
0; production was 1.3 nmol/min/mg of protein, and 
remained linear for up to 2 h. Subsequent levelling off 
was below the threshold for assay non-linearity, sug- 
gesting a limiting time duration of the response. In resi- 
dent macrophages, Rx produced a weak response at 
concentrations above 30 ng/ml, approximately 20% of 
the magnitude of the TPA response. Neither response 
was enhanced by treatment with zymosan. However, 
Rx proved a potent stimulator of the response in starch- 
elicited macrophages (Fig. 1). The maximal response 
obtained was more than 50% of that obtained with 
TPA, with a similar duration. Interestingly, treatment 
with Rx and zymosan was synergistic, inducing a 
response similar in magnitude to TPA. The TPA 
response was not enhanced by zymosan co-treatment. 
These results suggested that in resting macrophages, 
stimulation of the respiratory burst was mostly depen- 
dent on PKC isozyme activation, with the established 
requirements of PS and calcium, but in partially ac- 
tivated macrophages, the major portion of oxidative 
burst activation could be elicited by resiniferatoxin. To 
further investigate this possibility, the kinase isozyme 
profile from the supernatant of starch-elicited 
macrophage homogenates was determined following 
hydroxylapatite chromatography, and stimulation with 
Rx demonstrated the presence of a phospholipid and 
Table I 
Analysis of the most active, Rx kinase-containing hydroxylapatite 
fraction, used to stimulate Rx-dependent NADPH oxidase activity 
(Fig. Zii), illustrating selective Rx-stimulated, Ca*+-inhibited 
activation of kinase activity 
Compound Ca*+/EGTA 32P incorporation f SD 
(pmol/min/25 pl fraction) 
TPA 1 mM Ca*’ 18.9 + 5.47 
5 mM EGTA 12.0 ? 0.26 
Rx 1 mM Ca*+ 19.8 & 2.66 
5 mM EGTA 73.5 + 0.75* 
PS (alone) 1 mM Ca*+ 17.3 + 0.85 
5 mM EGTA 8.2 + 0.26 
Activity is shown as pmol diterpene ester-stimulated y-“*P 
incorporation/min into histone 111s using the micellar assay of 
Hannun et al. [lo]. Triton micelles contained diterpene esters where 
appropriate in a ratio of 0.003% and 20% PS (w/w). * P < 0.001, 
Student’s t-test 
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Fig. 2. Activation of NADPH-oxidase by diterpene sters in the presence of(i) PKC and (ii) Rx-kinase. Or was determined by a continuous kinetic 
assay of SOD-inhibitable reduction of cytochrome c. The assay mix contained in a final volume of 500 ,ul, 80 pM cytochrome c; 50 mM Nap04 
buffer @H 8.0) containing 20% glycerol, 5 mM EGTA, 1 mM MgClz, 0.1 M NaCl, 2 mM NaNs, 2 mM PMSF, 2 mM leupeptin and 2 mM DTT 
and 50 pl membrane protein, 50 ~1 cytosolic factor. The reference cuvette contained an additional 150 U SOD. For PKC and Rx-kinase studies 
the above buffer contained 100 PM ATP, 100 pg/ml PS, 10 mM MgClz, 10 mM EGTA or 5.2 mM CaClz together with the appropriate kinase 
fraction. The reaction was started by the addition of 100 ,cM NADPH-co-factor. Results are expressed by calculating the initial rate of 02 using 
the molar extinction coefficient of cytochrome c (21000 M-r.cm-r) + SD. (+) TPA + Ca”; (---o---) TPA - Ca’+; (-&-) Rx + Ca2+; 
(___A ___) Rx _ Ca2+. 
Rx-stimulated kinase activity inhibited by the presence 
of 1 mM Ca2+, corresponding to the Rx-kinase 
previously detected in human mononuclear cells [7] 
(Table I). Furthermore, in the presence of this enzyme 
fraction, Rx was capable of inducing a selective, dose- 
dependent activation of NADPH-oxidase solubilised 
from membrane fractions (Fig. 2). This activation re- 
quired the presence of exogenous ATP. Conversely, in 
the presence of mixed PKC isozymes at identical activi- 
ty, Rx was capable of only weak activation, whereas 
TPA induced a strong, Ca2+-dependent response. 
Rx is known to induce a pain response which appears 
to have a neurogenic basis and it has been proposed 
that Rx acts as an ultrapotent analogue of the 
neurotoxin capsaicin [ 11,121. Interestingly, in our 
assay, capsaicin differed from Rx, not merely in ef- 
ficacy (maximal response 30% that of Rx at 0.26 M), 
but in that the response was weakly antagonised by 
zymosan treatment. These results suggest hat Rx ac- 
tion on neurones may represent a special mechanism 
which is not applicable to ‘the fuller pharmacological 
spectrum of this complex molecule. 
In this report we have demonstrated that particulate 
stimuli, which are thought to activate the macrophage 
respiratory burst by kinase-independent mechanisms 
[131, can induce a conversion of activation re- 
quirements such that a major portion of the oxidative 
burst response can be activated by Rx. This diterpene 
is known to be a weak PKC activator but will activate 
a Ca2+ -independent kinase eluting from hydrox- 
ylapatite. This kinase activates the 
NADPH/cytochrome complex in cell-free assay and 
plays a distinct role in selective activation of primed 
macrophages. 
Acknowledgements: We are grateful to the MRC for a project grant 
and to the SERC for a studentship. This work was supported by the 
Wellcome Research and the Sandoz Institute for Medical Research. 
REFERENCES 
111 
t21 
t31 
141 
151 
161 
De Chatelet, L.R., Shirley, P.S. and Johnston, R.B. (1976) 
Blood 47, 545-554. 
Lehner, R.I. and Cohen, L. (1981) J. Clin. Invest. 68, 
1314-1320. 
Goldstein, B.D., Witz, G., Amoniso, M., Stone, D.S. and 
Troll, W. (1981) Cancer Lett. 11, 257-262. 
Cox, J.A., Jeng, J.A., Sharkey, N.A., Blumberg, P.M. and 
Tauber, A.I. (1985) J. Clin. Invest. 76, 1932-1938. 
Evans, F. J. and Edwards, M.C. (1987) Bot. J. Linnean Sot. 94, 
231-246. 
Ellis, C.A., Brooks, S.F., Brooks, G., Evans, A.T., Morrice, 
N., Evans, F.J. and Aitken, A. (1987) Phytother. Res. 1, 
187-190. 
255 
Volume 267, number 2 FEBSLETTERS July 1990 
[7] Ryves, W.J., Garland, LG., Evans, A.T. and Evans, F.J. 
(1989) FEBS Lett. 245, 159-163. 
[8] Evans, F.J. and Schmidt, R.J. (1979) Inflammation 3, 
215-223. 
[9] Johnston, R.B. (1984) Methods Enzymol. 105, 365-369. 
[lo] Hannun, Y .A., Loomis, C.R. and Bell, R.M. (1985) J. Biol. 
Chem. 260, 10039-10043. 
1111 Szallasi, A., Sharkey, N.A. and Blumberg, P.M. (1989) 
Phytother. Res. 3, 253-257. 
[12] De Vries, D.J. and Blumberg, P.M. (1989) Life Sci. 44, 
711-71s. 
1131 Andre, P., Capo, C., Mege, J.L., Benoliel, A.M. and Bon 
Grand, P. (1988) Biochem. Biophys. Res. Common. 151, 
641-648. 
256 
